$24.22
-0.31-1.26%
Last update: 1:42 PM
15 minutes delayed
Kiniksa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kiniksa Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-23 | $-0.06 | $-0.07 | 14.3 % |
Mar 2024 | 2024-04-23 | $-0.25 | $-0.16 | -56.3 % |
Dec 2023 | 2024-02-28 | $0.35 | $-0.14 | 350.0 % |
Sep 2023 | 2023-10-31 | $-0.20 | $-0.17 | -17.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-23 | $108.63M | $92.31M | 17.7 % |
Mar 2024 | 2024-04-23 | $79.86M | $78.46M | 1.78 % |
Dec 2023 | 2024-02-28 | $83.40M | $72.02M | 15.8 % |
Sep 2023 | 2023-10-31 | $67.05M | $64.45M | 4.03 % |
Kiniksa Pharmaceuticals (KNSA) is scheduled to report earnings on October 29, 2024. The last reported earnings were for reported on July 23, 2024 for Q2.
The Actual EPS was $-0.06, which beat the estimate of $-0.07.
The Actual Revenue was $108.6M, which beat the estimate of $92.3M.
Browse earnings estimates, EPS, and revenue on all stocks.